Indication
Schizophrenia
Schizophrenia is a chronic, severe neurodevelopmental and psychiatric disorder of the central nervous system that typically manifests during late adolescence or early adulthood. Read more about Schizophrenia
476 drugs 165 manufacturers
Drugs that treat it
Common Schizophrenia therapies.
HALOPERIDOL DECANOATE
CHLORPROMAZINE HCL
CHLORPROMAZINE HCL
ZIPRASIDONE HCL
CHLORPROMAZINE HCL
ARIPIPRAZOLE
ARIPIPRAZOLE
QUETIAPINE FUMARATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSchizophrenia is a chronic, severe neurodevelopmental and psychiatric disorder of the central nervous system that typically manifests during late adolescence or early adulthood.
It is clinically characterized by positive psychotic symptoms, including delusions, hallucinations, and disorganized thinking or behavior, alongside negative symptoms such as affective flattening, avolition, and social withdrawal, as well as significant cognitive deficits.
Pathophysiologically, the condition involves polygenic susceptibility and aberrant neurodevelopment, accompanied by functional dysregulation of central neurotransmitter systems—predominantly dopaminergic and glutamatergic pathways—and associated structural brain changes that collectively impair cognitive, emotional, and psychosocial functioning.
- nih.gov
Schizophrenia is a chronic, severe neurodevelopmental and psychiatric disorder of the central nervous system that typically manifests during late adolescence or early adulthood It is clinically characterized by positive psychotic symptoms, including delusions, hallucinations, and disorganized thinking or behavior, alongside negative symptoms such as affective flattening, avolition, and social withdrawal, as well as significant cognitive deficits Pathophysiologically, the condition involves polyg...
- nih.gov
Schizophrenia is a chronic, severe neurodevelopmental and psychiatric disorder of the central nervous system that typically manifests during late adolescence or early adulthood Pathophysiologically, the condition involves polygenic susceptibility and aberrant neurodevelopment, accompanied by functional dysregulation of central neurotransmitter systems—predominantly dopaminergic and glutamatergic pathways—and associated structural brain changes that collectively impair cognitive, emotional, and p...
- nih.gov
It is clinically characterized by positive psychotic symptoms, including delusions, hallucinations, and disorganized thinking or behavior, alongside negative symptoms such as affective flattening, avolition, and social withdrawal, as well as significant cognitive deficits
- nih.gov
It is clinically characterized by positive psychotic symptoms, including delusions, hallucinations, and disorganized thinking or behavior, alongside negative symptoms such as affective flattening, avolition, and social withdrawal, as well as significant cognitive deficits
Personalize your experience
Follow Schizophrenia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.